CUV 0.07% $15.26 clinuvel pharmaceuticals limited

CUV just came across my desk, after 2 days of research I see two...

  1. 310 Posts.
    lightbulb Created with Sketch. 13
    CUV just came across my desk, after 2 days of research I see two big red flags.

    1) Valuation is stretched - They'd have to making 75m profit a year indefinitely to justify the current price. Probably more if you assume a reasonably short lifespan that is typical of orphan drugs.
    2) Your relentless ramping...


    On point 1. If the US has 320m people @ 1:140,000, that's only 2,142 people @ c.20% addressable. Your talking an entire real US market of 428 people. That's using the companies figures.

    Please tell me I'm wrong, please?
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.